Lorenzo Di Bacco

ORCID: 0000-0002-0343-511X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Aortic Disease and Treatment Approaches
  • Cardiac Arrhythmias and Treatments
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Cardiac and Coronary Surgery Techniques
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Structural Anomalies and Repair
  • Cardiac Imaging and Diagnostics
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Function and Risk Factors
  • Infectious Aortic and Vascular Conditions
  • Aortic aneurysm repair treatments
  • Peripheral Artery Disease Management
  • Tracheal and airway disorders
  • Mechanical Circulatory Support Devices
  • Advanced X-ray and CT Imaging
  • COVID-19 and healthcare impacts
  • Central Venous Catheters and Hemodialysis
  • Cardiovascular Syncope and Autonomic Disorders
  • Antimicrobial Resistance in Staphylococcus
  • Phonocardiography and Auscultation Techniques
  • Congenital Heart Disease Studies
  • Cardiac electrophysiology and arrhythmias

University of Brescia
2016-2025

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2017-2025

Fundación Juan March
2023

Queen's University
2023

The Royal Melbourne Hospital
2023

New Zealand Association of Counsellors
2023

Fondazione Audiologica Varese
2022

Canadian Thoracic Society
2022

Istituto Clinico Sant'Ambrogio
2018-2021

CollegeAmerica
2020

Although the use of transcatheter aortic valve replacement (TAVR) has recently become an attractive strategy in extremely high-risk patients undergoing (AVR), most appropriate treatment option with intermediate- to profile conventional surgery (sAVR), TAVR or novel options, such as sutureless valves, been widely debated. One hundred and sixty-three consecutive intermediate high risk were prospectively enrolled selected undergo sAVR (Group 1: G1, n = 55), implantation 2: G2, 53) 3: G3, 55)...

10.1093/icvts/ivu340 article EN Interactive Cardiovascular and Thoracic Surgery 2014-10-15

Minimally invasive hybrid revascularization (MIHR) by means of the left mammary artery on anterior descending [minimally direct coronary bypass (MIDCAB)] combined with percutaneous interventions (PCI) stenting may be an alternative to conventional grafting through sternotomy or multiple PCI. The purpose this study is retrospectively evaluate long-term outcomes strategy. Since May 1997 up January 2011, 810 MIDCAB have been performed as isolated in 644 patients. 2004, MIDCAB, a part...

10.1093/ejcts/ezt016 article EN European Journal of Cardio-Thoracic Surgery 2013-02-26

Objective To report the early and mid-term results of patients who underwent minimally invasive aortic valve replacement (MI-AVR) with a sutureless prosthesis from an international prospective registry. Methods Between March 2011 September 2018, among 957 included in observational SURE-AVR (Sorin Universal REgistry on Aortic Valve Replacement) registry, 480 MI-AVR self-expandable Perceval bioprosthesis (LivaNova PLC, London, UK) 29 institutions through either minithoracotomy ( n = 266) or...

10.1177/1556984519892585 article EN Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery 2019-12-26

Current guidelines recommend concomitant surgical ablation (SA) of atrial fibrillation (AF) in the context mitral valve disease. A variety energy sources have been tested for SA to perform effective transmural lesions reliably. To date, only radiofrequency and cryothermy energies are considered viable options. The gold standard is Cox-Maze set, especially non-paroxysmal AF (nPAF), with aim interrupting macro-reentrant drivers perpetuating AF, without hampering sinus node activation both...

10.21037/acs-2023-afm-0208 article EN Annals of Cardiothoracic Surgery 2024-03-01

Objectives: Heart failure (HF) remains a significant public health issue, with heart transplantation (HT) being the gold standard treatment for end-stage HF. The increasing use of mechanical circulatory support, particularly left ventricular assist devices (LVADs), as bridge to transplant (BTT), presents new perspectives increasingly complex clinical scenarios. This study aimed compare long-term outcomes in patients reduced ejection fraction (HFrEF) receiving an LVAD BTT those undergoing...

10.3390/jcm14010275 article EN Journal of Clinical Medicine 2025-01-06

Background: New-onset postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery, occurring approximately in one-third of patients. This study considered all-comer patients who underwent surgery to build a predictive model for POAF. Methods: A total 3467 (Center 1) consecutive were used as derivation cohort model. The POLARIS score was then derived proportionally from odds ratios obtained following multivariable logistic regression (MLR). Brier Score, area...

10.3390/jcm14020650 article EN Journal of Clinical Medicine 2025-01-20

Abstract OBJECTIVES Mitral Annular Disjunction (MAD) is an abnormal displacement of the posterior mitral leaflet into left atrial wall, potentially leading to ventricular dysfunction, malignant arrhythmias (VA) and sudden cardiac death. This study investigates outcomes patients with without MAD undergoing valve repair for prolapse (MVP). METHODS The retrospectively collected a single-center experience from 2021 2023 on 326 consecutive MVP. Patients were divided two groups according presence...

10.1093/ejcts/ezaf029 article EN European Journal of Cardio-Thoracic Surgery 2025-02-01

Background: Acute aortic valve infective endocarditis (IE) presents a critical surgical timing dilemma. This study investigates whether early intervention (within seven days of targeted antibiotic therapy initiation) affects mortality and clinical outcomes compared to delayed/conventional surgery. Methods: A retrospective, multicenter analysis 204 patients with IE was conducted, excluding emergency cases requiring immediate intervention. Patients were stratified into EARLY (≤7 days) LATE...

10.3390/jcdd12040153 article EN cc-by Journal of Cardiovascular Development and Disease 2025-04-11

Abstract Introduction Hybrid coronary artery revascularization (HCR) brings advantages of both percutaneous (PCI) and surgical techniques while minimizing risk complications. In particular, minimally invasive strategy (MICS) for LAD with the use internal thoracic harvested either robot–assisted or via left–sided minithoracotomy, provides excellent long–term benefits that have been extensively demonstrated. some circumstances, unprotected PCI may represent a clinical challenge interventional...

10.1093/eurheartjsupp/suaf076.179 article EN European Heart Journal Supplements 2025-05-01

Abstract Introduction Staged hybrid strategies for combined cardiac diseases demonstrated to provide the best therapeutic option in high–risk patients while reducing drawbacks of surgical and/or percutaneous procedures alone. In particular, dividing overall risk morbidity and mortality a concomitant procedure into staged approach, factorization each single intervention may lead reduced complication per se. Clinical case We report 74yo female with hypertension, dyslipidemia family history...

10.1093/eurheartjsupp/suaf076.182 article EN European Heart Journal Supplements 2025-05-01

Abstract Introduction Minimally invasive revascularization techniques for myocardial (MICS) of the left anterior descending coronary artery (LAD) with internal thoracic (LITA) include robot–assisted (RACAB) or direct minithoracotomy (MIDCAB) approaches. These strategies, alone combined PCI in a hybrid setting, provide excellent survival outcomes while minimizing risk complications especially morbidly high–risk patients. We report early clinical patients who underwent MICS. Methods From...

10.1093/eurheartjsupp/suaf076.023 article EN European Heart Journal Supplements 2025-05-01

The HISTORIC-AF trial is a prospective, multicentre, single-arm study designed to evaluate the outcomes of staged endoscopic and transcatheter ablation in patients with stand-alone, persistent or long-standing atrial fibrillation (AF). From 2012 2015, 100 consecutive were enrolled underwent thoracoscopic left epicardial isolation ('box lesion') followed by case AF recurrency. safety end point was composite outcome freedom from major adverse events at 30-days, while efficacy points were: (i)...

10.1093/ejcts/ezx162 article EN European Journal of Cardio-Thoracic Surgery 2017-05-16

Aims Timing and surgical strategies in acute infective endocarditis are still questionable. We sought to investigate clinical outcomes of patients undergoing mitral valve repair (MVR) compared with replacement [mitral prosthesis (MVP)] for endocarditis. Methods From 2004 2019, 109 consecutive were retrospectively investigated. Patients divided into two groups according strategy: MVR 53/109 (48.6%) versus MVP 56/109 (51.4%). Primary end points in-hospital mortality overall survival at 10...

10.2459/jcm.0000000000001544 article EN Journal of Cardiovascular Medicine 2023-08-03
Coming Soon ...